Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic
  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Penny Stock Momentum Watchlist (SWISF, IMTL, NIR, TSOI)

Investors consistently seek out factors that could influence price fluctuations. A significant catalyst that frequently exerts a profound influence on prices is news. Favorable news possesses the potential to propel stocks to remarkable heights

Let’s take a closer look at four stocks with recent significant news.

Sekur Private Data Ltd. (OTCQX:SWISF) (CSE:SKUR) 

Sekur Private Data is rapidly expanding its reach and offerings, signaling a bright future in the realm of cybersecurity and internet privacy.

A key development in Sekur's growth strategy is the recent advertising partnership and distribution agreement with VYRE Network, a global news-based streaming channel and website with a substantial viewership of over 1 million worldwide. This strategic alliance aims to bolster Sekur's presence in the United States, targeting the vast market of small businesses. With a focus on cybersecurity and internet privacy, Sekur offers a suite of secure communication services designed to address data mining concerns and vulnerabilities present in many existing solutions.

One of the notable aspects of this partnership is the placement of Sekur commercials and banner ads throughout the VYRE Network's streaming news website. In return, Sekur will share revenue generated from new signups, with a primary focus on attracting enterprise and investor audiences. This move aligns with Sekur's broader strategy to roll out its enterprise communication services, including the SekurMessenger app, SekurMail, and SekurVPN, with additional products in the pipeline for future release.

Furthermore, Sekur is expanding its presence beyond the United States. In Morocco, the company is collaborating with Digital Smart Solution Sarl (DSS), an IT services consulting company, to introduce SekurMessenger to prominent companies in the telecommunications and banking sectors. This expansion into new markets underscores Sekur's commitment to providing robust cybersecurity solutions on a global scale.

One of Sekur's standout offerings is SekurMessenger, an app that offers end-to-end encryption and advanced security features like VirtualVaults and Helix Tech. Notably, SekurMessenger does not require users to provide a phone number during sign-up, enhancing privacy by design. The recent introduction of the "chat-by-invite" feature ensures that secure communication remains accessible even to individuals who don't have the app. This feature simplifies the process of maintaining privacy when interacting with external parties, making it a valuable tool for businesses looking to safeguard sensitive data and internal communications.

SekurMail and SekurVPN complement the company's suite of security solutions, providing secure email communications and an additional layer of protection against hacking and malware attacks. Looking ahead, Sekur has ambitious plans, including the launch of SekurVoice, slated for Q1 2024. This upcoming addition will enable users to make encrypted calls globally without the need for traditional phone numbers, further enhancing their privacy and security.

With these strategic moves and innovative products, Sekur Private Data Ltd. is poised to carve out a significant presence in the cybersecurity and internet privacy sectors, offering solutions tailored to the evolving needs of businesses and individuals in an increasingly digital world.

Looking For Stocks Ready To Explode? Join Our FREE Newsletter http://capitalgainsreport.com

Image Protect Inc. (OTC:IMTL)

On Tuesday, IMTL, a prominent player in the end-to-end copyright infringement sector, shared exciting news with investors. The company announced that during the second quarter, it successfully achieved debt forgiveness exceeding $1,400,000, encompassing convertible debt, principal, and accrued interest, courtesy of its largest lender. This development has kindled optimism among stakeholders about the company's future prospects.

This remarkable debt forgiveness arose from a legal judgment entered on May 2, 2023, in the case SEC v. GPL Ventures et al., 21 Civ. 6814 (S.D.N.Y.). As part of this judgment, GPL Ventures and related parties were mandated to surrender all unconverted convertible notes to Image Protect Inc., as outlined in an appendix to the judgment. The financial stability resulting from this maneuver is seen as a positive step.

CEO James Ballas, in acknowledging the significance of this financial development, expressed optimism about the company's financial health. Importantly, this move reduces the potential for dilution, thereby benefiting existing shareholders. What's even more intriguing is that it clears the path for a pending joint venture or acquisition of an established national brand in the technology sector. The company plans to make a formal announcement regarding this development within the next two weeks, adding an element of anticipation to the equation.

IMTL had risen by an impressive 25% as of 1 p.m. on Wednesday. The recent debt forgiveness and the forthcoming announcement of a strategic move in the technology sector have stirred speculation about the stock's potential for further growth. Investors are closely watching, and the stock seems poised for a potentially promising journey ahead.

Near Intelligence, Inc. (NASDAQ:NIR)

NIR is a global data intelligence platform gaining prominence in data analytics and business intelligence. With a diverse clientele across industries like retail, real estate, and telecom, Near is poised for substantial growth.

Near excels in curating vast data intelligence on individuals and locations. Utilizing patented technology, Near analyzes data from 1.6 billion unique user IDs across 70 million points of interest in 44 countries. This empowers businesses to make intelligent decisions, enhancing profitability.

The company recently announced the appointment of two distinguished individuals to its Board of Directors: Richard J. Salute and Sherman Edmiston III.

Richard J. Salute, a seasoned CPA, brings a wealth of experience in accounting, complex audits, and strategic planning for both public and private companies. His appointment as chairperson of the Audit Committee highlights his commitment to ensuring financial rigor within the company.

Sherman Edmiston III, with a background in financial and operational advisory services, has a strong track record in corporate leadership and currently serves on multiple corporate boards. His expertise will play a crucial role in guiding Near's strategic direction.

These additions to Near's board reflect the company's dedication to diversity and expertise across technology, accounting, and business strategy. Their insights will be invaluable as Near continues its growth trajectory.

Furthermore, Near has forged partnerships with leading global commercial real estate (CRE) companies. These firms collectively generate an impressive annual revenue of nearly $87 billion and manage assets exceeding $200 billion.

Near's expansion into new regions and client relationships highlight its growth potential. Exclusive access to high-quality data has the opportunity for NIR to position themselves as a data intelligence leader.

The firm's data analytics, covering geographical insights from DMAs to neighborhoods, aids businesses in adapting to evolving consumer dynamics and data-driven decision-making.

As businesses increasingly rely on data-driven decision-making, Near' global data intelligence platform could position it for sustained success.

Therapeutic Solutions International, Inc. (OTC: TSOI)

Therapeutic Solutions is making strides in the field of immunotherapy with its subsidiary company, Res Nova Bio, revealing a potential breakthrough. While traditional wisdom suggests that stem cell administration promotes cancer growth due to the growth factors produced by stem cells, Res Nova scientists discovered that various types of mesenchymal stem cells can enhance the efficacy of immunotherapies that activate T cells. This preliminary data suggests that regenerative cell administration can alter the tumor environment, making it more accessible to T cells. The company is actively seeking partners to further explore this promising discovery.

Dr. Famela Ramos, President and CEO of Res Nova, emphasized the urgency for innovative cancer treatment approaches. Dr. James Veltmeyer, Chief Medical Officer, praised Res Nova's rapid progress in leveraging technologies from stem cells to pharmaceuticals to create preclinical and early clinical products.

The company operates in the golden age of cancer immunotherapy, focusing on enhancing the efficacy of therapies that struggle to penetrate solid tumors. For instance, while CAR-T cells have shown remarkable results in blood cancer, their effectiveness is limited in many other cancer types.

In another strategic move, Therapeutic Solutions International has appointed Dr. Navneet Boddu, a renowned stem cell therapist, to its Scientific Advisory Board. Dr. Boddu has previously obtained emergency IND approval to treat COVID-19 patients using JadiCells, and the company plans to expand patient access to this treatment as it advances in development.

Dr. Thomas Ichim, a board member of Therapeutic Solutions International, praised Dr. Boddu's combination of scientific excellence, medical expertise, and business acumen. Dr. Boddu's affiliations with prominent medical centers and recognition as a Top Doctor of San Diego further solidify his reputation in the field.

The company's diverse portfolio includes initiatives targeting various medical conditions, such as aortic aneurysms, chronic traumatic encephalopathy, chronic obstructive pulmonary disease, mental illness, and oncology. Collaborating with a pioneer like Dr. Boddu, who has extensive experience with the FDA, is expected to accelerate the progress of these programs through regulatory channels.

Therapeutic Solutions International is an emerging force in advancing regenerative medicine, making strides toward addressing critical medical challenges. These developments position the company as a noteworthy penny stock in the field.

 

 

Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance that are not statements of historical fact may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Sekur Private Data Ltd. to assist in the production and distribution of content related to SWISF. 'CGR'  is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.

Media Contact
Company Name: Capital Gains Report
Contact Person: Mark McKelvie
Email: Send Email
City: NAPLES
State: FLORIDA
Country: United States
Website: https://capitalgainsreport.com/


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.